vs
Brookfield Business Corp（BBUC）与Encompass Health Corp（EHC）财务数据对比。点击上方公司名可切换其他公司
Brookfield Business Corp的季度营收约是Encompass Health Corp的1.2倍（$1.9B vs $1.5B），Encompass Health Corp净利率更高（9.5% vs -1.2%，领先10.7%），Encompass Health Corp同比增速更快（9.9% vs -3.6%）
布鲁克菲尔德商业合伙有限合伙企业是一家公开上市的有限合伙企业，是母公司布鲁克菲尔德集团旗下私募股权投资板块商业服务与工业业务的主要公众持股平台，于2016年6月从布鲁克菲尔德资产管理公司分拆成立。
Encompass Health Corp前身为Amcare及HealthSouth，总部位于美国阿拉巴马州伯明翰，是美国规模最大的住院康复服务提供商，在39个州及波多黎各拥有173家住院康复医院，为中风、神经系统疾病、心肺病症、脑损伤等患者提供专业康复诊疗服务。
BBUC vs EHC — 直观对比
营收规模更大
BBUC
是对方的1.2倍
$1.5B
营收增速更快
EHC
高出13.5%
-3.6%
净利率更高
EHC
高出10.7%
-1.2%
损益表 — Q2 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.9B | $1.5B |
| 净利润 | $-23.0M | $146.1M |
| 毛利率 | — | — |
| 营业利润率 | — | 16.7% |
| 净利率 | -1.2% | 9.5% |
| 营收同比 | -3.6% | 9.9% |
| 净利润同比 | -157.5% | 20.8% |
| 每股收益（稀释后） | — | $1.43 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BBUCEHC
| Q4 25 | — | $1.5B | ||
| Q3 25 | — | $1.5B | ||
| Q2 25 | $1.9B | $1.5B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | — | $1.4B | ||
| Q2 24 | $1.9B | $1.3B | ||
| Q1 24 | — | $1.3B |
净利润BBUCEHC
| Q4 25 | — | $146.1M | ||
| Q3 25 | — | $126.5M | ||
| Q2 25 | $-23.0M | $142.1M | ||
| Q1 25 | — | $151.5M | ||
| Q4 24 | — | $120.9M | ||
| Q3 24 | — | $108.2M | ||
| Q2 24 | $40.0M | $114.1M | ||
| Q1 24 | — | $112.5M |
营业利润率BBUCEHC
| Q4 25 | — | 16.7% | ||
| Q3 25 | — | 14.9% | ||
| Q2 25 | — | 16.2% | ||
| Q1 25 | — | 16.4% | ||
| Q4 24 | — | 14.3% | ||
| Q3 24 | — | 13.6% | ||
| Q2 24 | — | 14.3% | ||
| Q1 24 | — | 13.6% |
净利率BBUCEHC
| Q4 25 | — | 9.5% | ||
| Q3 25 | — | 8.6% | ||
| Q2 25 | -1.2% | 9.7% | ||
| Q1 25 | — | 10.4% | ||
| Q4 24 | — | 8.6% | ||
| Q3 24 | — | 8.0% | ||
| Q2 24 | 2.1% | 8.8% | ||
| Q1 24 | — | 8.5% |
每股收益（稀释后）BBUCEHC
| Q4 25 | — | $1.43 | ||
| Q3 25 | — | $1.24 | ||
| Q2 25 | — | $1.39 | ||
| Q1 25 | — | $1.48 | ||
| Q4 24 | — | $1.18 | ||
| Q3 24 | — | $1.06 | ||
| Q2 24 | — | $1.12 | ||
| Q1 24 | — | $1.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $613.0M | $72.2M |
| 总债务越低越好 | — | $2.4B |
| 股东权益账面价值 | $2.6B | $2.4B |
| 总资产 | $16.3B | $7.1B |
| 负债/权益比越低杠杆越低 | — | 1.00× |
8季度趋势，按日历期对齐
现金及短期投资BBUCEHC
| Q4 25 | — | $72.2M | ||
| Q3 25 | — | $48.7M | ||
| Q2 25 | $613.0M | $99.1M | ||
| Q1 25 | — | $95.8M | ||
| Q4 24 | — | $85.4M | ||
| Q3 24 | — | $147.8M | ||
| Q2 24 | $754.0M | $154.4M | ||
| Q1 24 | — | $134.4M |
总债务BBUCEHC
| Q4 25 | — | $2.4B | ||
| Q3 25 | — | $2.4B | ||
| Q2 25 | — | $2.3B | ||
| Q1 25 | — | $2.3B | ||
| Q4 24 | — | $2.4B | ||
| Q3 24 | — | $2.3B | ||
| Q2 24 | — | $2.7B | ||
| Q1 24 | — | $2.7B |
股东权益BBUCEHC
| Q4 25 | — | $2.4B | ||
| Q3 25 | — | $2.4B | ||
| Q2 25 | $2.6B | $2.3B | ||
| Q1 25 | — | $2.2B | ||
| Q4 24 | — | $2.1B | ||
| Q3 24 | — | $2.0B | ||
| Q2 24 | $4.6B | $1.8B | ||
| Q1 24 | — | $1.7B |
总资产BBUCEHC
| Q4 25 | — | $7.1B | ||
| Q3 25 | — | $6.9B | ||
| Q2 25 | $16.3B | $6.8B | ||
| Q1 25 | — | $6.6B | ||
| Q4 24 | — | $6.5B | ||
| Q3 24 | — | $6.5B | ||
| Q2 24 | $20.5B | $6.4B | ||
| Q1 24 | — | $6.2B |
负债/权益比BBUCEHC
| Q4 25 | — | 1.00× | ||
| Q3 25 | — | 1.01× | ||
| Q2 25 | — | 1.02× | ||
| Q1 25 | — | 1.08× | ||
| Q4 24 | — | 1.14× | ||
| Q3 24 | — | 1.20× | ||
| Q2 24 | — | 1.46× | ||
| Q1 24 | — | 1.54× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $346.0M |
| 自由现金流经营现金流 - 资本支出 | — | $116.7M |
| 自由现金流率自由现金流/营收 | — | 7.6% |
| 资本支出强度资本支出/营收 | — | 14.8% |
| 现金转化率经营现金流/净利润 | — | 2.37× |
| 过去12个月自由现金流最近4个季度 | — | $439.2M |
8季度趋势，按日历期对齐
经营现金流BBUCEHC
| Q4 25 | — | $346.0M | ||
| Q3 25 | — | $270.8M | ||
| Q2 25 | — | $270.2M | ||
| Q1 25 | — | $288.6M | ||
| Q4 24 | — | $278.8M | ||
| Q3 24 | — | $267.8M | ||
| Q2 24 | — | $217.4M | ||
| Q1 24 | — | $238.8M |
自由现金流BBUCEHC
| Q4 25 | — | $116.7M | ||
| Q3 25 | — | $83.7M | ||
| Q2 25 | — | $113.3M | ||
| Q1 25 | — | $125.5M | ||
| Q4 24 | — | $80.1M | ||
| Q3 24 | — | $120.3M | ||
| Q2 24 | — | $60.5M | ||
| Q1 24 | — | $99.4M |
自由现金流率BBUCEHC
| Q4 25 | — | 7.6% | ||
| Q3 25 | — | 5.7% | ||
| Q2 25 | — | 7.8% | ||
| Q1 25 | — | 8.6% | ||
| Q4 24 | — | 5.7% | ||
| Q3 24 | — | 8.9% | ||
| Q2 24 | — | 4.6% | ||
| Q1 24 | — | 7.6% |
资本支出强度BBUCEHC
| Q4 25 | — | 14.8% | ||
| Q3 25 | — | 12.7% | ||
| Q2 25 | — | 10.8% | ||
| Q1 25 | — | 11.2% | ||
| Q4 24 | — | 14.1% | ||
| Q3 24 | — | 10.9% | ||
| Q2 24 | — | 12.1% | ||
| Q1 24 | — | 10.6% |
现金转化率BBUCEHC
| Q4 25 | — | 2.37× | ||
| Q3 25 | — | 2.14× | ||
| Q2 25 | — | 1.90× | ||
| Q1 25 | — | 1.90× | ||
| Q4 24 | — | 2.31× | ||
| Q3 24 | — | 2.48× | ||
| Q2 24 | — | 1.91× | ||
| Q1 24 | — | 2.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BBUC
暂无分部数据
EHC
| Medicare | $1.0B | 66% |
| Medicare Advantage | $243.1M | 16% |
| Managed Care | $160.7M | 10% |
| Medicaid | $47.0M | 3% |
| Other Income Source | $44.8M | 3% |
| Other Thirdparty Payors | $11.2M | 1% |
| Workers Compensation | $7.6M | 0% |
| Patients | $4.6M | 0% |
